A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)
Kim BK, Hong MK, RESET Investigators.
KEYWORDS
DAPT duration; Dual antiplatelet therapy (DAPT); DES; bleeding; coronary stenting